Navigation Links
HealthSport, Inc. Announces Issuance of Mexican Patent
Date:2/3/2010

OXNARD, Calif., Feb. 3 /PRNewswire-FirstCall/ -- HealthSport, Inc. (OTC Bulletin Board: HSPO), the preeminent formulator and developer of edible, multi-layer film strips that deliver drug and dietary supplement actives through buccal and sublingual absorption as well as oral ingestion, announced today that the Mexican Institute of Industrial Property has approved HealthSport's patent application relating to its bi-layer edible film strip technology.  

The patent issuance opens the door for sales and distribution into Mexico, and is expected to accelerate HealthSport's move into the international marketplace.  The Mexican market for OTC drugs is larger than that of China and is a natural next step into international sales and distribution of HealthSport's products.  

The issuance of the Mexican patent also strengthens HealthSports's commitment to develop products based on it's next-generation drug delivery technology.

"We have long recognized the unique value that our film strip technology can provide to consumers through a number of different products, and the recently issued Mexican patent reinforces this belief, further demonstrating the proprietary nature of our technology."  

HealthSport currently has seven additional patent applications pending in the U.S. and several other countries.

About HealthSport, Inc.

HealthSport, Inc. (www.healthsportinc.com) is a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional su
'/>"/>

SOURCE HealthSport, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million
2. HealthSport, Inc. Announces Agreement for $10 Million Investment by SMI Manufacturing
3. BioSpecifics Technologies Corp. Announces FDA Approval of XIAFLEX(TM) for Treatment of Dupuytrens Contracture
4. Vermillion Announces the Reappointment of Officers and Confirmation of Director
5. Upsher-Smith Announces New Formulation of PreNexa(R) Prenatal Vitamins
6. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
7. ISTA Pharmaceuticals Announces Preliminary, Unaudited Revenue of $110.6 Million in 2009
8. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
9. BIA Announces Release of Solis(TM) Integrated ESI Management and E-Discovery Platform
10. Pioneer(R) Surgical Technology, Inc. Announces New Expansion Plan
11. Cardica Announces Fiscal 2010 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)...  AbbVie (NYSE: ABBV ) has announced that ... its New Drug Application (NDA) and granted priority review ... of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin (RBV). The ... genotype 4 (GT4) hepatitis C virus (HCV) infection. ... being evaluated by the FDA for patients in ...
(Date:4/23/2015)... , April 23, 2015 Once again, ... strengthening our commitment to patient safety. BeaconMedaes, ... fight against infectious disease. The next generation ... Medical gas sensors are now mounted in the assembly, ... need to open ceiling tiles potentially releasing dust spores ...
(Date:4/23/2015)... FRANCISCO , April 23, 2015 Nektar Therapeutics ... the first quarter ended March 31, 2015 on Thursday, April ... Howard Robin , president and chief executive officer, will host ... p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... the conference call can be accessed through a link that ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7BeaconMedaes launches new Zone Valve Box Assembly 2Nektar to Announce Financial Results for the First Quarter 2015 on Thursday, April 30, 2015, After Close of U.S.-Based Financial Markets 2
... Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company ... from its consumer trial with Allumera™, a breakthrough cosmetic ... The RevitAll study was performed with a standard ... Allumera™ improves skin appearance, when compared to exposure by ...
... Inc. (Hologic or the Company) (Nasdaq: ... of premium diagnostics products, medical imaging systems and ... of women, announced today the U.S. Food and ... Makena™ (hydroxyprogesterone caproate injection), formerly known as Gestiva™. ...
Cached Medicine Technology:Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 2Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 3Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements 4FDA Approves Hologic's Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical 2
(Date:4/26/2015)... Aliso Viejo, CA (PRWEB) April 26, 2015 ... Final Cut Pro X editors can quickly and ... a Lookup Table that contains a mathematical formula for modifying ... corresponding color indicated by the table. This pack comes with ... was inspired by vintage and contemporary black and white films. ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 This annual ... of the season and will include a spectacular collection ... totes, collectibles, herbal soaps and incense, chimes, vases, candleholders, ... this year’s exciting and unique collection of vendors, guests ... with Jim Martocci and the Jimmie Jazz Band. ...
(Date:4/26/2015)... Memphis, TN (PRWEB) April 26, 2015 ... plans to grow throughout the Southeast. MidSouth Pain Treatment ... clinic locations in Cordova, Southaven, Oxford and Jackson, two ... CLIA-certified laboratory in the Southaven and Cordova locations. , ... said ”I went into medicine to help people, ...
(Date:4/25/2015)... April 25, 2015 In observance of ... join The Million Nets Pledge, a two-year pledge by ... protect refugee families with one million bednets by 2016. ... work with UN partners to protect children, refugees, and ... , “There has been a large surge in ...
(Date:4/25/2015)... Carinsurancequotesinfo.com has released a new blog post ... insurance for flatbed trucks. , Flatbed trucks ... vehicles. They are mainly used for commercial purposes and ... post explains that by comparing multiple offers, drivers can ... commercial vehicles. , It is now possible to compare ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2
... majority of advanced colon cancer patients in a clinical ... drugs for managing chemotherapy side effects, such as infection, ... drug cost burdens after joining the clinical trial, according ... Institute in Boston. Although few patients reported substantial worry ...
... -- PRA International, a leading Clinical Research ... audioconference and announces it will exhibit at the 2009 ... Florida, May 30 through June 1. The audioconference, which ... 2009, and was presented by John Constant, PhD, PRA,s ...
... U.S. Food and Drug Administration (FDA) announced today that ... for Pharmaceutical Science and Clinical Pharmacology to discuss bioequivalence ... The meeting is scheduled for August 4, 2009. ... no later than two days before the meeting at ...
... 29 The J. Craig Venter Institute (JCVI) announced ... five year contract from the National Institute of Allergy ... of Health, as one of their Genomic Sequencing Centers ... Nierman, Ph.D., and Robert Strausberg, Ph.D., the contract will ...
... DeterminedToQuit.com translated to Estoydecidido.com for Latino PennsylvaniansHARRISBURG, ... Health Everette James today announced the launch ... Latino residents of Pennsylvania go tobacco free.Estoydecidido.com ... - is the Spanish version of the ...
... finds student military veterans face some unique health issuesMINNEAPOLIS/ST. ... expected to go to school this fall as a ... will need to ensure student veterans, unique needs are ... issued Friday by the University of Minnesota ...
Cached Medicine News:Health News:One in ten advanced colon cancer patients worry about prescription drug costs 2Health News:PRA International Oncology Experts at ASCO 2Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 2Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 3Health News:ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products 4Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 3Health News:PA Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 2Health News:Student Veteran Health Examined in First-of-Its-Kind Study by University of Minnesota/Minnesota State Colleges and Universities 3
... is now the first manufacturer to ... to the wearer. These next generation ... clarity, an ultra-lightweight design, and are ... scratch resistance. With SheerVision's proprietary SureFit ...
For face-lifts and submental liposuction...
Ideal for autoplasty and liposuction of chin and cheeks...
Facial Mask...
Medicine Products: